Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations

被引:26
作者
Colonne, Chanukya K. [1 ]
Reardon, Benjamin [1 ]
Curnow, Jennifer [2 ,3 ,4 ]
Favaloro, Emmanuel J. [1 ,4 ,5 ]
机构
[1] Westmead Hosp, NSW Hlth Pathol, Inst Clin Pathol & Med Res ICPMR, Dept Haematol, Sydney, NSW, Australia
[2] Westmead Hosp, Dept Clin Haematol, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[4] Sydney Ctr Thrombosis & Haemostasis, Sydney, NSW, Australia
[5] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia
来源
JOURNAL OF BLOOD MEDICINE | 2021年 / 12卷
关键词
von Willebrand disease; VWD; diagnosis; FACTOR SURVIVAL; SHORT HISTORY; DIAGNOSIS; TYPE-1; PATHOPHYSIOLOGY; IDENTIFICATION; PROPEPTIDE; UPDATE; ASSAYS; TESTS;
D O I
10.2147/JBM.S266791
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite von Willebrand disease (VWD) being the most common inherited bleeding disorder, its accurate diagnosis is frequently shrouded by diagnostic pitfalls. VWD is frequently under-diagnosed, over-diagnosed and misdiagnosed, leading to significant avoidable patient morbidity and health care system burden. At the heart of this dilemma lies the heterogeneity and complexity of von Willebrand factor (VWF) and associated defects, and the necessity of coalescing clinical and laboratory features to obtain an accurate diagnosis. Common pitfalls include poor clinical and scientific understanding and familiarity with VWD, incomplete clinical history and lack of routine use of standardised bleeding assessment tools (BAT), difficulty in accessing a comprehensive repertoire of laboratory tests, significant pre-analytical, analytical and post-analytical issues, and lack of expertise in laboratory testing and interpretation. Errors, resulting in under-diagnosis, over-diagnosis, and misdiagnosis of VWD, are presented and discussed. Strategies to minimise errors include better education of clinicians and laboratory staff on VWD, routine use of validated BAT, utilising a comprehensive gamut of laboratory investigations according to a standardised algorithm, and repeating testing to minimise pre-analytical errors. Recommendations on appropriate patient selection for VWD testing, how VWD should be investigated in the laboratory, and how to ensure test results are accurately interpreted in the correct clinical context are detailed.
引用
收藏
页码:755 / 768
页数:14
相关论文
共 35 条
[1]   Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues [J].
Abebe, Worku .
EPMA JOURNAL, 2019, 10 (01) :51-64
[2]   von Willebrand disease update: diagnostic and treatment dilemmas [J].
Bolton-Maggs, P. H. B. ;
Lillicrap, D. ;
Goudemand, J. ;
Berntorp, E. .
HAEMOPHILIA, 2008, 14 :56-61
[3]   The prevalence of symptomatic von Willebrand disease in primary care practice [J].
Bowman, M. ;
Hopman, W. M. ;
Rapson, D. ;
Lillicrap, D. ;
James, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :213-216
[4]   Haemostatic changes in pregnancy [J].
Brenner, B .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :409-414
[5]   Overdiagnosis: what it is and what it isn't [J].
Brodersen, John ;
Schwartz, Lisa M. ;
Heneghan, Carl ;
O'Sullivan, Jack William ;
Aronson, Jeffrey K. ;
Woloshin, Steven .
BMJ EVIDENCE-BASED MEDICINE, 2018, 23 (01) :1-3
[6]   Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method [J].
Cabrera, N. ;
Moret, A. ;
Caunedo, P. ;
Cid, A. R. ;
Vila, V. ;
Espana, F. ;
Aznar, J. A. .
HAEMOPHILIA, 2013, 19 (06) :920-925
[7]   von Willebrand's disease diagnosis and laboratory issues [J].
Castaman, G. ;
Montgomery, R. R. ;
Meschengieser, S. S. ;
Haberichter, S. L. ;
Woods, A. I. ;
Lazzari, M. A. .
HAEMOPHILIA, 2010, 16 :67-73
[8]   von Willebrand Factor Assay Proficiency Testing The North American Specialized Coagulation Laboratory Association Experience [J].
Chandler, Wayne L. ;
Peerschke, Ellinor I. B. ;
Castellone, Donna D. ;
Meijer, Piet .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (06) :862-869
[9]   Developments in the diagnostic procedures for von Willebrand disease [J].
De Jong, A. ;
Eikenboom, J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (03) :449-460
[10]   Performance of two new automated assays for measuring von Willebrand activity: HemosIL Acu Star and Innovance [J].
de Maistre, Emmanuel ;
Volot, Fabienne ;
Mourey, Guillaume ;
Aho, Ludwig S. ;
Ternisien, Catherine ;
Briquel, Marie-Elisabeth ;
Bertrand, Marie-Anne ;
Tardy, Brigitte ;
Frotscher, Birgit ;
Nguyen, Philippe ;
Dumont, Laure ;
Vandroux, David ;
Hezard, Nathalie ;
Trossaert, Marc .
THROMBOSIS AND HAEMOSTASIS, 2014, 112 (04) :825-830